Скачать или смотреть Optimizing Physical Form in Drug Development: Key Strategies & Insights | Dr. Sudhakar Garad

At the 2024 "Unlocking Early Drug Development" Symposium held at the Parc Científic of Barcelona, Dr. Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling at NIBR, shares his expert insights on how the physical form of a drug influences solubility, dissolution, and absorption. In this engaging presentation, he explains the importance of BCS classification and emphasizes the need to lock in a stable physical form early in the development process. Sudhakar discusses practical techniques—such as salt selection, co-crystallization, and solid dispersion—to overcome formulation challenges and accelerate the transition from preclinical studies to clinical applications.

Drawing on over 20 years of industry experience and real-world case studies, his talk highlights the critical role of early collaboration between chemists, formulators, and biopharmaceutical experts to ensure successful and cost-effective drug development.

Subscribe for more expert insights and innovative strategies in pharmaceutical development!

Contact us

📍Parc Científic de Barcelona
c/ Baldiri Reixac, 10-12
08028 Barcelona

🌐 https://solitekpharma.com/
🤝   / solitekpharma  
💬 [email protected]

Solitek - Solid Technologies SL, your partner crystallization, solid state and preclinical drug development services

#UnlockingEarlyDrugDevelopment #SudhakarGarad #DrugDevelopment #PharmaceuticalInnovation #SolidState #FormulationScience #SolitekSymposium2024